Published in Brain on August 01, 2002
Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol (2010) 7.97
Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol (2010) 2.77
Adult-onset drug-refractory seizure disorder associated with anti-voltage-gated potassium-channel antibody. Epilepsia (2009) 1.88
Nervous system KV7 disorders: breakdown of a subthreshold brake. J Physiol (2008) 1.47
Movement disorders in paraneoplastic and autoimmune disease. Curr Opin Neurol (2011) 1.28
KV7 channelopathies. Pflugers Arch (2010) 1.20
Opening paths to novel analgesics: the role of potassium channels in chronic pain. Trends Neurosci (2014) 1.16
Paraneoplastic neurological syndromes. Clin Exp Immunol (2014) 1.12
Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1. Brain (2010) 1.05
Paraneoplastic diseases associated with thymoma. J Neurol (2007) 1.01
The clinical spectrum of Caspr2 antibody-associated disease. Neurology (2016) 0.97
Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders. Hematol Oncol Clin North Am (2006) 0.96
Corticomotoneuronal function and hyperexcitability in acquired neuromyotonia. Brain (2010) 0.95
An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre. J Neurol (2014) 0.95
Anti-Ri antibodies associated with short-term memory deficits and a mature cystic teratoma of the ovary. Int Semin Surg Oncol (2004) 0.92
Autoimmune causes of encephalitis syndrome in Thailand: prospective study of 103 patients. BMC Neurol (2013) 0.85
Autoimmune channelopathies: well-established and emerging immunotherapy-responsive diseases of the peripheral and central nervous systems. J Clin Immunol (2010) 0.83
Acquired neuromyotonia heralding recurrent thymoma in myasthenia gravis. JAMA Neurol (2013) 0.83
Acquired neuromyotonia following upper respiratory tract infection: a case report. Cases J (2009) 0.81
Reactions of the immune system in epilepsy. Maedica (Buchar) (2010) 0.80
The emerging diversity of neuromuscular junction disorders. Acta Myol (2007) 0.80
Axonal Excitability in Amyotrophic Lateral Sclerosis : Axonal Excitability in ALS. Neurotherapeutics (2016) 0.79
Fasciculation anxiety syndrome in clinicians. J Neurol (2013) 0.78
A Chinese female Morvan patient with LGI1 and CASPR2 antibodies: a case report. BMC Neurol (2016) 0.77
Autoantibodies in neuromuscular transmission disorders. Ann Indian Acad Neurol (2008) 0.77
Antibody testing as a diagnostic tool in autonomic disorders. Clin Auton Res (2008) 0.77
A case of neuromyotonia in Behçet disease during TNF-α antagonist therapy. Neurol Sci (2014) 0.77
Autoimmune channelopathies of the nervous system. Curr Neuropharmacol (2011) 0.76
Adult-onset Satoyoshi syndrome and response to plasmapheresis. Ann Indian Acad Neurol (2016) 0.75
Positive muscle phenomena--diagnosis, pathogenesis and associated disorders. Nat Rev Neurol (2012) 0.75
Topiramate-Induced Persistent Eyelid Myokymia. Case Rep Psychiatry (2016) 0.75
Netrin-1 receptor antibodies in thymoma-associated neuromyotonia with myasthenia gravis. Neurology (2017) 0.75
Voltage-gated potassium channelopathy: an expanding spectrum of clinical phenotypes. BMJ Case Rep (2013) 0.75
The enlarged extraocular muscle: to relax, reflect or refer? Eye (Lond) (2016) 0.75
Wasp sting induced autoimmune neuromyotonia. J Neurol Neurosurg Psychiatry (2006) 0.75
A 48-year-old man with syncope and diffuse muscle twitches. Neurohospitalist (2012) 0.75
A 45-year history of acquired autoimmune neuromyotonia. J Neurol (2006) 0.75
Paraneoplastic neuromyotonia due to lung carcinoma and invisible muscle cramps evaluated using ultrasonography. J Neurooncol (2017) 0.75
Isaacs' syndrome with overlapping myopathy as the first manifestation of AL amyloidosis. J Neurol (2016) 0.75
Clinical features of limbic encephalitis with LGI1 antibody. Neuropsychiatr Dis Treat (2017) 0.75
Normal human CD4(+) helper T cells express Kv1.1 voltage-gated K(+) channels, and selective Kv1.1 block in T cells induces by itself robust TNFα production and secretion and activation of the NFκB non-canonical pathway. J Neural Transm (Vienna) (2015) 0.75
Neuromyotonia as an unusual neurological complication of primary Sjögren's syndrome: case report and literature review. Clin Rheumatol (2016) 0.75
Morvan syndrome: a rare cause of syndrome of inappropriate antidiuretic hormone secretion. Clujul Med (2017) 0.75
A possible mechanism of repetitive firing of myelinated axon. Pflugers Arch (2009) 0.75
Clinical, Electrophysiological, and Serological Evaluation of Patients with Cramp-Fasciculation Syndrome. Noro Psikiyatr Ars (2016) 0.75
Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis (2010) 7.60
Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol (2011) 6.77
Open letter to prime minister David Cameron and health secretary Andrew Lansley. BMJ (2010) 4.52
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain (2010) 3.95
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology (2012) 3.67
Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain (2013) 3.22
Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol (2012) 3.12
IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. Brain (2008) 2.91
Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol (2010) 2.54
Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol (2008) 2.48
Autoantibodies in sporadic Creutzfeldt-Jakob disease. JAMA Neurol (2013) 2.42
Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol (2008) 2.40
Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre. J Neurol Neurosurg Psychiatry (2013) 2.33
Disease-relevant autoantibodies in first episode schizophrenia. J Neurol (2010) 2.33
Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system. Nat Med (2007) 2.28
Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy. Arch Neurol (2009) 2.25
Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations. Brain (2006) 2.25
Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit. Crit Care Med (2010) 2.24
Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. J Neurol Neurosurg Psychiatry (2012) 2.21
Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain (2012) 2.17
Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry (2012) 2.15
N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol (2009) 2.03
Voltage-gated potassium channel antibodies in limbic encephalitis. Ann Neurol (2003) 2.02
Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Arch Neurol (2010) 1.99
GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction. Nat Genet (2013) 1.91
Autoimmunity against the β2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome. Pain (2011) 1.89
Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol (2004) 1.89
Dok-7 mutations underlie a neuromuscular junction synaptopathy. Science (2006) 1.88
Maternal neuronal antibodies associated with autism and a language disorder. Ann Neurol (2003) 1.69
Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis. Arch Neurol (2012) 1.67
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain (2012) 1.65
EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer. Cancer Prev Res (Phila) (2011) 1.65
Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int MS J (2008) 1.61
Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med (2007) 1.61
Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese. Neurology (2004) 1.56
N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse. Mov Disord (2013) 1.55
Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain. Ann Neurol (2012) 1.54
Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies. Clin Neurophysiol (2006) 1.54
Neurology training in the United Kingdom: a diagnostic analysis of over 5000 patients. J Neurol (2005) 1.52
EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays. Tumour Biol (2012) 1.52
Pilomotor seizures and status in non-paraneoplastic limbic encephalitis. Epileptic Disord (2005) 1.47
Late EEG responses triggered by transcranial magnetic stimulation (TMS) in the evaluation of focal epilepsy. Epilepsia (2007) 1.46
An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus. Nature (2007) 1.46
Antibody-mediated encephalitis: a treatable cause of schizophrenia. Br J Psychiatry (2012) 1.45
Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci (2010) 1.45
A candidate gene for autoimmune myasthenia gravis. Neurology (2012) 1.44
The expanding spectrum of clinically-distinctive, immunotherapy-responsive autoimmune encephalopathies. Arq Neuropsiquiatr (2012) 1.43
Hand-held nerve conduction device in carpal tunnel syndrome: a prospective study. Muscle Nerve (2012) 1.40
Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies. JAMA Neurol (2013) 1.40
Reporting clinical trials: full access to all of the data. Arch Neurol (2002) 1.39
Antibodies to voltage-gated potassium and calcium channels in epilepsy. Epilepsy Res (2006) 1.39
Antiglycine-receptor encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry (2010) 1.38
Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis. Ann Neurol (2006) 1.37
Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults. Lancet Neurol (2008) 1.32
Autoimmune disorders of neuronal potassium channels. Ann N Y Acad Sci (2003) 1.32
Elevated VGKC-complex antibodies in a boy with fever-induced refractory epileptic encephalopathy in school-age children (FIRES). Dev Med Child Neurol (2011) 1.32
Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets. Lancet Neurol (2003) 1.32
Ion channels in genetic and acquired forms of epilepsy. J Physiol (2012) 1.24
HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome. J Neuroimmunol (2004) 1.23
Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia (2013) 1.22
Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS. J Clin Oncol (2011) 1.21
NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease. J Neurol (2012) 1.21
Immune-mediated steroid-responsive epileptic spasms and epileptic encephalopathy associated with VGKC-complex antibodies. Dev Med Child Neurol (2011) 1.20
Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann Neurol (2005) 1.20
Immunobiomarkers in small cell lung cancer: potential early cancer signals. Clin Cancer Res (2010) 1.20
Rectification of the EMG is an unnecessary and inappropriate step in the calculation of Corticomuscular coherence. J Neurosci Methods (2011) 1.19
Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels. Br J Pharmacol (2005) 1.19
MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain (2006) 1.18
Clinical features of the DOK7 neuromuscular junction synaptopathy. Brain (2007) 1.17
Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia. J Neurol Neurosurg Psychiatry (2012) 1.16
Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients. Muscle Nerve (2004) 1.15
Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Ann Neurol (2005) 1.14
Muscle activity and acceleration during whole body vibration: effect of frequency and amplitude. Clin Biomech (Bristol, Avon) (2010) 1.14
Autoimmune epilepsy in children: case series and proposed guidelines for identification. Epilepsia (2013) 1.13
Which antibody and which cancer in which paraneoplastic syndromes? Pract Neurol (2010) 1.13
T cell deficiency does not reduce lesions in mice produced by intracerebral injection of NMO-IgG and complement. J Neuroimmunol (2011) 1.12
Autoimmune encephalitis -- new awareness, challenging questions. Discov Med (2011) 1.11
Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES. Neuropediatrics (2012) 1.11
Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis. Neurology (2012) 1.11
The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study. Arch Dermatol (2010) 1.10
Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission. Epilepsia (2010) 1.10
Clinical and serological study of myasthenia gravis in HuBei Province, China. J Neurol Neurosurg Psychiatry (2006) 1.10
Autoimmune mediated neuromuscular junction defects. Curr Opin Neurol (2010) 1.09
Amyotrophic lateral sclerosis with sensory neuropathy: part of a multisystem disorder? J Neurol Neurosurg Psychiatry (2007) 1.09
Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms. Ann Neurol (2014) 1.08
EMG rectification has inconsistent effects on coherence analysis even in single motor unit studies. J Neurophysiol (2014) 1.08
Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients. J Neurol (2010) 1.08
Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort. J Neurol Neurosurg Psychiatry (2013) 1.07
Secondary nonresponsiveness to botulinum toxin A in cervical dystonia: the role of electromyogram-guided injections, botulinum toxin A antibody assay, and the extensor digitorum brevis test. Mov Disord (2006) 1.07
Paraneoplastic limbic encephalitis associated with potassium channel antibodies: value of anti-glial nuclear antibodies in identifying the tumour. J Neurol Neurosurg Psychiatry (2007) 1.06